# The Development, Safety, and Feasibility of an Artificial Intelligence-Powered Platform (NodeAI) for Real-Time Prediction of Mediastinal Lymph Node Malignancy During Endobronchial Ultrasound Staging for Lung Cancer

> **NCT06540196** · NA · RECRUITING · sponsor: **St. Joseph's Healthcare Hamilton** · enrollment: 600 (estimated)

## Conditions studied

- Lung Cancer
- Non Small Cell Lung Cancer

## Interventions

- **DIAGNOSTIC_TEST:** NodeAI
- **DIAGNOSTIC_TEST:** Surgeon

## Key facts

- **NCT ID:** NCT06540196
- **Lead sponsor:** St. Joseph's Healthcare Hamilton
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-01-10
- **Primary completion:** 2026-12-31
- **Final completion:** 2026-12-31
- **Target enrollment:** 600 (ESTIMATED)
- **Last updated:** 2025-06-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06540196

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06540196, "The Development, Safety, and Feasibility of an Artificial Intelligence-Powered Platform (NodeAI) for Real-Time Prediction of Mediastinal Lymph Node Malignancy During Endobronchial Ultrasound Staging for Lung Cancer". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06540196. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*